Editorial: Advances in drug-induced diseases

Yao Liu; Jia-Bo Wang; Linan Zeng; Maxine Gossell-Williams; Patricia Moriel; Miao Yan

doi:10.3389/fphar.2023.1193099

Editorial: Advances in drug-induced diseases

Front Pharmacol. 2023 Apr 11:14:1193099. doi: 10.3389/fphar.2023.1193099. eCollection 2023.

Authors

Yao Liu¹, Jia-Bo Wang², Linan Zeng^{3

4}, Maxine Gossell-Williams⁵, Patricia Moriel⁶, Miao Yan^{7

8

9}

Affiliations

¹ Department of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
² School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
³ Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
⁴ Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada.
⁵ Section of Pharmacology and Pharmacy, Faculty of Medical Sciences Teaching and Research Complex, University of the West Indies, Kingston, Jamaica.
⁶ Faculty of Pharmaceutical Sciences, University of Campinas, Campinas, Brazil.
⁷ Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
⁸ Hunan Provincial Center for Poison Information and Treatment, Changsha, Hunan, China.
⁹ International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, Hunan, China.

No abstract available

Keywords: Editorial; FAERS; adverse drug reactions; drug safety; drug-induced diseases.

Publication types

Editorial

Grants and funding

This study was funded by the Chongqing Special Project for Technological Innovation and Application Development (NO. CSTC2021jscx-gksb-N0013) and the Chongqing Clinical Pharmacy Key Specialties Construction Project.